pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 545 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 3
latarcibart
latarcibart [INN]
Von Willebrand Disease (vWD)
$STHOStar Holdings
0 catalysts
Phase 3
lenadogene nolparvovec
LUMEVOQ (lenadogene nolparvovec [INN])
Leber's Hereditary Optic Neuropathy (Leber Optic Atrophy)
GenSight Biologics SA
0 catalysts
Phase 3
lepodisiran sodium
Atherosclerosis
Eli Lilly and Co
0 catalysts
← prev
page 12 of 19
next →
131
Pain89
Neurology1
Phase 3
levosimendan
Pulmonary Hypertension
Phosphodiesterase 3Troponin, cardiac muscle
$TENXTENAX THERAPEUTICS, INC.
0 catalysts
Phase 3
licaminlimab
Keratoconjunctivitis Sicca (Dry Eye)
$OCSOculis Holding AG
0 catalysts
Phase 3
lifileucel
Amtagvi (lifileucel)
Metastatic Melanoma
$IOVAIOVANCE BIOTHERAPEUTICS, INC.
0 catalysts
Phase 3
lingdolinurad
lingdolinurad [INN]
Gouty Arthritis (Gout)
Atom Therapeutics Co Ltd
0 catalysts
Phase 3
linsitinib
Graves' Ophthalmopathy
Insulin receptorInsulin-like growth factor 1 receptor
Sling Therapeutics Inc
0 catalysts
Phase 3
linzagolix choline
Pain
Gonadotropin-releasing hormone receptor
Kissei Pharmaceutical Co Ltd
0 catalysts
Phase 3
lisaftoclax
lisaftoclax [INN]
Myelodysplastic Syndrome (Preleukemia)
$AAPGASCENTAGE PHARMA GROUP INTERNATIONAL
0 catalysts
Phase 3
litifilimab
Cutaneous Lupus Erythematosus
C-type lectin domain family 4 member C
$BIIBBIOGEN INC.
0 catalysts
Phase 3
lonapegsomatropin LA
TransCon hGH (lonapegsomatropin-tcgd)
Turner Syndrome
Growth hormone receptor
Ascendis Pharma AS
0 catalysts
Phase 3
lonimecgene renparvovec
Rett Syndrome
$TSHATaysha Gene Therapies, Inc.
0 catalysts
Phase 3
lonvoguran
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency)
$NTLAIntellia Therapeutics, Inc.
0 catalysts
Phase 3
lovotibeglogene autotemcel
Lyfgenia (lovotibeglogene autotemcel)
Sickle Cell Disease
Hemoglobin subunit beta
Genetix Biotherapeutics Inc
0 catalysts
Phase 3
lucerastat
Fabry Disease
Ceramide glucosyltransferase
Idorsia Pharmaceutical Ltd
0 catalysts
Phase 3
lutadenovec autogene + sapecmeran autogene
Metastatic Colorectal Cancer
Nexoplex Bio LLC
0 catalysts
Phase 3
lutetium (177Lu) rosopatamab tetraxetan
lutetium (177Lu) rosopatamab tetraxetan [INN]
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
$TLXTelix Pharmaceuticals Ltd
0 catalysts
Phase 3
lutetium (177Lu) zadavotide guraxetan
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Curium Midco Sarl
0 catalysts
Phase 3
lysergide tartrate
Major Depressive Disorder
$DFTXDefinium Therapeutics, Inc.
0 catalysts
Phase 3
mRNA-1403
Norovirus Infections
$MRNAModerna, Inc.
0 catalysts
Phase 3
masitinib
masitinib [INN]
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
AB Science SA
0 catalysts
Phase 3
masupirdine
masupirdine [INN]
Dementia Associated With Alzheimer's Disease
Suven Life Sciences Ltd
0 catalysts
Phase 3
meningococcal [serotype B] vaccine
Bexsero
Neisseria meningitidis Infections
Neisserial heparin binding antigen
$GSKGSK plc
0 catalysts
Phase 3
mesdopetam
mesdopetam [INN]
Drug-Induced Dyskinesia
IRLAB Therapeutics AB
0 catalysts
Phase 3
metreleptin
Myalept (metreleptin [INN])
Familial Partial Lipodystrophy
Amryt Pharma Plc
0 catalysts
Phase 3
mezagitamab
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1
$TAKTAKEDA PHARMACEUTICAL CO LTD
0 catalysts
Phase 3
mezigdomide
Refractory Multiple Myeloma
Bristol-Myers Squibb Co
0 catalysts
Phase 3
mibavademab
mibavademab [INN]
Acquired Generalized Lipodystrophy (Lawrence Syndrome)
$REGNREGENERON PHARMACEUTICALS, INC.
0 catalysts
Phase 3
miconazole
ORAVIG (miconazole [INN])
Otitis Externa
Hill Dermaceuticals Inc
0 catalysts